16.Studying Chronic Graft-versus-Host Disease (Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it. 17.New Strategy for Treatment-Resistant Solid Tumors in Children (Posted: 06/13/2006) - This clinical trial will assess the safety of of a drug called talabostat in combination with chemotherapy in pediatric patients with cancer who have not responded to or gotten worse after other treatments. 18.Targeted Combination Therapy for Advanced Solid Tumors (Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined. 19.Immunotoxin Therapy for Advanced Solid Tumors (Posted: 09/21/2004) - Researchers with this trial will test the safety of a new drug called SS1(dsFv)-PE38 (SS1P) in patients who have advanced mesothelin-expressing cancers.
